Marjolein de Bruijn

2PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 27, 2022
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.

Paulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis

|Jul 09, 2021
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.

Paula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen

Pageof 1